Emeis Exits Latin America with €111M Divestment, Focuses on European Core
Event summary
- Emeis completed the sale of all its Latin American operations for €111M, excluding remaining land plots in Mexico and Colombia.
- The divestment covers 15 facilities with nearly 1,500 beds across Brazil, Mexico, Uruguay, and Chile as of late 2023.
- Total enterprise value for Latin American divestments, including pending land sales, reaches approximately €132M.
- The region contributed negatively to EBITDAR (-€1.5M) in 2025, making the disposal immediately accretive.
- Emeis expects to finalize the sale of remaining land plots by year-end for approximately €20M.
The big picture
Emeis's exit from Latin America aligns with a broader trend of healthcare providers streamlining operations to focus on core, profitable markets. The €111M divestment reflects a strategic shift towards European operations, where the company can leverage its scale of 84,600 experts and professionals. The move also underscores the financial discipline required to manage a mission-driven company with significant social commitments.
What we're watching
- Financial Impact
- How the €111M divestment will affect Emeis's deleveraging trajectory and balance sheet strength.
- Execution Risk
- The pace at which Emeis can finalize the sale of remaining land plots in Mexico and Colombia.
- Strategic Focus
- Whether Emeis can successfully reposition itself in core European markets post-divestment.
Related topics